Insulin signalling and insulin actions in the muscles and livers of insulin-resistant, insulin receptor substrate 1-deficient mice.
about
Essential role of insulin receptor substrate-2 in insulin stimulation of Glut4 translocation and glucose uptake in brown adipocytesActivation of the insulin receptor by insulin and a synthetic peptide leads to divergent metabolic and mitogenic signaling and responsesTissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistanceGosha-jinki-gan (a Herbal Complex) Corrects Abnormal Insulin SignalingThe Novel Functions of High-Molecular-Mass Complexes Containing Insulin Receptor Substrates in Mediation and Modulation of Insulin-Like Activities: Emerging Concept of Diverse Functions by IRS-Associated ProteinsPrevention of fat-induced insulin resistance by salicylateInhibition of RXR and PPARgamma ameliorates diet-induced obesity and type 2 diabetesOverexpression of the LAR (leukocyte antigen-related) protein-tyrosine phosphatase in muscle causes insulin resistanceDevelopment of non-insulin-dependent diabetes mellitus in the double knockout mice with disruption of insulin receptor substrate-1 and beta cell glucokinase genes. Genetic reconstitution of diabetes as a polygenic diseaseBlockade of IRS1 in isolated rat pancreatic islets improves glucose-induced insulin secretionHIV-protease inhibitors induce expression of suppressor of cytokine signaling-1 in insulin-sensitive tissues and promote insulin resistance and type 2 diabetes mellitusA novel spontaneous mutation of Irs1 in mice results in hyperinsulinemia, reduced growth, low bone mass and impaired adipogenesis.Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolismEssential role of insulin receptor substrate 1 (IRS-1) and IRS-2 in adipocyte differentiation.PTEN expression causes feedback upregulation of insulin receptor substrate 2Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance.Insights into insulin resistance and type 2 diabetes from knockout mouse models.Insulin receptor substrate (IRS) transduction system: distinct and overlapping signaling potential.Decreased gene expressions of insulin signal molecules in canine hyperadrenocorticism.Insulin receptor substrate polymorphisms and type 2 diabetes mellitus.Molecular mechanisms of insulin resistance.Genetic engineering in mice: impact on insulin signalling and action.Enhanced gastrointestinal expression of cytosolic malic enzyme (ME1) induces intestinal and liver lipogenic gene expression and intestinal cell proliferation in mice.Vascular signaling pathways in the metabolic syndrome.Nexilin, a cardiomyopathy-associated F-actin binding protein, binds and regulates IRS1 signaling in skeletal muscle cells.Molecular insights into insulin action and secretion.An association between a common variant (G972R) in the IRS-1 gene and sex hormone levels in post-menopausal breast cancer survivorsMolecular mechanisms of insulin resistance in type 2 diabetes mellitusOverexpression of insulin receptor substrate-2 in human and murine hepatocellular carcinoma.Insulin receptor substrate 1 (IRS1) variants confer risk of diabetes in the Boston Puerto Rican Health Study.BMI-related progression of atypical PKC-dependent aberrations in insulin signaling through IRS-1, Akt, FoxO1 and PGC-1α in livers of obese and type 2 diabetic humansIs there an estrogenic component in the metabolic syndrome?Cellular location of insulin-triggered signals and implications for glucose uptake.Insulin receptor substrate-2 maintains predominance of anabolic function over catabolic function of osteoblasts.Differential signaling by insulin receptor substrate 1 (IRS-1) and IRS-2 in IRS-1-deficient cells.Protein kinase C-zeta phosphorylates insulin receptor substrate-1, -3, and -4 but not -2: isoform specific determinants of specificity in insulin signaling.Haloperidol and olanzapine mediate metabolic abnormalities through different molecular pathways.12-Lipoxygenase Inhibition on Microalbuminuria in Type-1 and Type-2 Diabetes Is Associated with Changes of Glomerular Angiotensin II Type 1 Receptor Related to Insulin Resistance.Modulation by dietary fat and carbohydrate of IRS1 association with type 2 diabetes traits in two populations of different ancestriesInterruption of growth hormone signaling via SHC and ERK in 3T3-F442A preadipocytes upon knockdown of insulin receptor substrate-1.
P2860
Q22254159-31662B76-164C-4F9F-B8BA-FDA84D38AF3BQ24297068-FE1C19BA-5411-4C11-8C2A-77790EEE41B0Q24629603-957171E7-4C33-496D-9DFC-23496095ACB3Q24808749-AEAEE581-6EE8-417E-A3D4-F48F49DE873CQ28088661-7AB08D96-B643-47EE-8E06-8E4EF40D9AC5Q28345600-D7BAF9C9-B455-4D6E-A3ED-0A4D9A30757FQ28360697-8581F68A-5A09-474F-85C0-718B96A2166EQ28363155-B6619611-0E20-45C4-AC17-AF0A87E3DB9FQ28510789-7E2E9F2D-9E6B-434A-929A-5B9D0AC64965Q28577340-41C6005B-0214-4133-A308-39F3CA9047A0Q28582686-AAD81337-889A-465A-AB4C-A2A0FFE4ECB1Q30476716-D2D5A9EC-9ECB-4722-8D1A-B1B146A58CA5Q33830715-28073BAF-EF3A-4028-8263-890F3E64387FQ33967843-2AC5C2B3-A164-4C07-B10D-F3B6850646DFQ33968441-2832CB5D-5217-4A23-9688-9FB937A91653Q33997240-FC62B24D-B4C7-445F-8BB9-152DA0A56EC0Q34011039-2829412A-18D8-4263-BCBF-2A20F3E03426Q34103184-29D54CB6-ED55-49EA-919C-688AA9182E48Q34136664-79339F37-70D7-4796-A517-09AEEB5F2035Q34188504-76FF6208-2775-4E88-8A04-C8CED6291861Q34420707-9E137317-CF8B-41CE-B6C8-41719F284BEDQ34474052-C19AA736-08C6-4DDF-B7FC-FD76EA9F4807Q34526895-D2141C8B-506F-4967-946F-E15325E5F571Q34555130-2D11BBE7-BD0D-41AA-B539-A209D47DEEC3Q34576839-D434E5DE-6A85-4B0C-9A66-ABF47C719CACQ34655565-1522164A-AAA3-440B-BA34-89C4CD763933Q34712486-EB4EDF5D-85E0-4659-8A54-3799C82A34A7Q34877773-C8A0DE37-5A5F-4C26-8915-12C74858F5AFQ35221770-17F0E685-3A83-4E7A-8F64-9EB9BDF409B2Q35598032-E7859A52-6471-418E-B2D5-8F4EBA5AC924Q36077931-58E66227-BD0F-4945-BF48-32844A0F4752Q36267934-735F090A-5294-4CF8-BF85-2732EEBE1648Q36311897-885A211D-502F-429B-A85C-E1B3A9EF51F7Q36324480-E728C8B0-90EB-4BC9-A4F3-7064419ED0D3Q36566004-0B8C4FCA-CB48-4E10-9805-AEA7885C3643Q36578889-BFECF46E-ADB7-495F-9478-822A899120CAQ36593819-12146F19-298F-4CE7-B2C3-FCC6A45B0B61Q36939224-D65EA674-0851-4908-AB36-A330F5EF1697Q37106352-FCCDF900-DDB4-49CA-AF24-7708C2DD1E50Q37155400-9A9C8E64-AF36-4E84-B272-9E42FCF32C38
P2860
Insulin signalling and insulin actions in the muscles and livers of insulin-resistant, insulin receptor substrate 1-deficient mice.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Insulin signalling and insulin ...... or substrate 1-deficient mice.
@en
type
label
Insulin signalling and insulin ...... or substrate 1-deficient mice.
@en
prefLabel
Insulin signalling and insulin ...... or substrate 1-deficient mice.
@en
P2093
P2860
P356
P1476
Insulin signalling and insulin ...... or substrate 1-deficient mice.
@en
P2093
Kaburagi Y
Kadowaki T
Sonenberg N
Takahashi Y
Tamemoto H
Yamamoto-Honda R
P2860
P304
P356
10.1128/MCB.16.6.3074
P407
P577
1996-06-01T00:00:00Z